Cadwalader Advises Accelus on $482 Million Combination with CHP Merger Corporation

November 15, 2021

Cadwalader is advising Integrity Implants Inc. (d/b/a Accelus) in its definitive business combination agreement with CHP Merger Corporation (NASDAQ: CHPM), a special acquisition company (SPAC), in a transaction with an implied enterprise value of approximately $482 million. Upon the closing of the business combination, CHP Merger Corp. will be renamed Accelus. The business combination is expected to be completed in early 2022.

Based in Palm Beach Gardens, Florida, Accelus is a commercial stage medical technology company with a mission to accelerate the adoption of minimally invasive surgery as the standard of care in spine. With a portfolio of MIS spinal implants leveraging its proprietary Adaptive GeometryTM technology and a compact precision robotics platform, Accelus is focused on improving procedures and outcomes, creating favorable economics, and providing broad accessibility across end markets, including ambulatory surgery centers and internationally.

The Cadwalader team includes Corporate partners Stephen Fraidin, Greg Patti andJoanna Valentine, special counsel Erica Hogan and associates Dmitry Morgan, Camillo Di Donato and Steven Szaro, Litigation special counsel Aaron Lang and Tax special counsel Joseph Soltis.